Search results
Results From The WOW.Com Content Network
Sirtris Pharmaceuticals, Inc. was a biotechnology company based in Cambridge, MA that developed therapies for type 2 diabetes, cancer, and other diseases. Conceived in 2004 by Harvard University biologist David Sinclair and Andrew Perlman, [1] and founded that year by Sinclair and Perlman, along with Christoph Westphal, Richard Aldrich, Richard Pops, and Paul Schimmel, [2] the company was ...
The Sackler family is an American family who owned the pharmaceutical company Purdue Pharma and later founded Mundipharma. [1] Purdue Pharma, and some members of the family, have faced lawsuits regarding overprescription of addictive pharmaceutical drugs, including OxyContin.
Purdue Pharma L.P., formerly the Purdue Frederick Company (1892–2019), was an American privately held pharmaceutical company founded by John Purdue Gray. It was sold to Arthur , Mortimer , and Raymond Sackler in 1952, and then owned principally by the Sackler family and their descendants.
Sinclair Oil Corporation was an American petroleum corporation founded by Harry F. Sinclair on May 1, 1916. The Sinclair Oil and Refining Corporation amalgamated the assets of 11 small petroleum companies. [3] Originally a New York corporation, Sinclair Oil reincorporated in Wyoming in 1976. [4]
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
An FDA director who oversaw the approval of OxyContin got a $400K gig at Purdue Pharma a year later. A new book by Patrick Radden Keefe reported on these claims and on the billionaire Sackler family.
Mundipharma International Limited is a British multinational research-based pharmaceutical company owned by members of the Sackler family with locations in United Kingdom, Canada, Germany, and Singapore. [2] In Germany, Mundipharma is a subsidiary of Mundipharma International Limited and Mundipharma AG.
On average, it takes over a decade and $2.3 billion for a pharmaceutical company to develop a new medication, an expensive slog that few companies want to risk tinkering with. Introducing a new ...